Delayed
Japan Exchange
02:00:00 2024-05-02 am EDT
|
5-day change
|
1st Jan Change
|
3,960
JPY
|
-0.38%
|
|
+4.76%
|
+11.39%
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
85,830
|
90,395
|
80,794
|
81,805
|
99,800
|
111,169
|
-
|
-
|
Enterprise Value (EV)
1 |
47,286
|
48,444
|
39,070
|
34,637
|
56,041
|
111,169
|
111,169
|
111,169
|
P/E ratio
|
3.14
x
|
25.9
x
|
24
x
|
20.8
x
|
24.2
x
|
22.8
x
|
19.7
x
|
16.5
x
|
Yield
|
1.57%
|
1.49%
|
1.67%
|
3.43%
|
3.38%
|
3.03%
|
3.03%
|
3.09%
|
Capitalization / Revenue
|
2
x
|
2.17
x
|
1.72
x
|
1.67
x
|
1.83
x
|
1.92
x
|
1.82
x
|
1.66
x
|
EV / Revenue
|
2
x
|
2.17
x
|
1.72
x
|
1.67
x
|
1.83
x
|
1.92
x
|
1.82
x
|
1.66
x
|
EV / EBITDA
|
35.5
x
|
17
x
|
15.9
x
|
13.6
x
|
18.2
x
|
17.9
x
|
14.6
x
|
12.1
x
|
EV / FCF
|
2.12
x
|
21.6
x
|
-48.8
x
|
42.8
x
|
-14.5
x
|
18.8
x
|
20.3
x
|
29.5
x
|
FCF Yield
|
47.1%
|
4.63%
|
-2.05%
|
2.34%
|
-6.92%
|
5.32%
|
4.93%
|
3.39%
|
Price to Book
|
0.76
x
|
0.79
x
|
0.69
x
|
0.69
x
|
0.83
x
|
0.92
x
|
0.9
x
|
0.88
x
|
Nbr of stocks (in thousands)
|
28,049
|
28,073
|
28,073
|
28,073
|
28,073
|
28,073
|
-
|
-
|
Reference price
2 |
3,060
|
3,220
|
2,878
|
2,914
|
3,555
|
3,960
|
3,960
|
3,960
|
Announcement Date
|
2/6/20
|
2/4/21
|
2/10/22
|
2/10/23
|
2/9/24
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
42,998
|
41,700
|
46,987
|
48,896
|
54,638
|
57,800
|
61,220
|
66,900
|
EBITDA
1 |
2,415
|
5,320
|
5,069
|
5,994
|
5,494
|
6,218
|
7,606
|
9,169
|
EBIT
1 |
1,430
|
4,738
|
4,656
|
5,540
|
5,035
|
6,050
|
7,095
|
8,550
|
Operating Margin
|
3.33%
|
11.36%
|
9.91%
|
11.33%
|
9.22%
|
10.47%
|
11.59%
|
12.78%
|
Earnings before Tax (EBT)
1 |
37,700
|
4,225
|
4,767
|
5,722
|
5,593
|
6,550
|
7,592
|
9,060
|
Net income
1 |
27,367
|
3,495
|
3,374
|
3,944
|
4,119
|
4,885
|
5,652
|
6,730
|
Net margin
|
63.65%
|
8.38%
|
7.18%
|
8.07%
|
7.54%
|
8.45%
|
9.23%
|
10.06%
|
EPS
2 |
975.0
|
124.5
|
120.1
|
140.4
|
146.6
|
173.8
|
201.2
|
239.4
|
Free Cash Flow
1 |
40,400
|
4,182
|
-1,654
|
1,912
|
-6,902
|
5,913
|
5,485
|
3,770
|
FCF margin
|
93.96%
|
10.03%
|
-3.52%
|
3.91%
|
-12.63%
|
10.23%
|
8.96%
|
5.64%
|
FCF Conversion (EBITDA)
|
1,672.88%
|
78.61%
|
-
|
31.9%
|
-
|
95.09%
|
72.11%
|
41.12%
|
FCF Conversion (Net income)
|
147.62%
|
119.66%
|
-
|
48.48%
|
-
|
121.04%
|
97.04%
|
56.02%
|
Dividend per Share
2 |
48.00
|
48.00
|
48.00
|
100.0
|
120.0
|
120.0
|
120.0
|
122.5
|
Announcement Date
|
2/6/20
|
2/4/21
|
2/10/22
|
2/10/23
|
2/9/24
|
-
|
-
|
-
|
Fiscal Period: December |
2020 S1
|
2021 S1
|
2021 Q3
|
2022 Q1
|
2022 S1
|
2022 Q3
|
2023 Q1
|
2023 S1
|
2023 Q3
|
2024 Q1
|
---|
Net sales
1 |
19,857
|
21,555
|
11,882
|
10,960
|
23,102
|
12,213
|
11,811
|
25,699
|
13,433
|
13,451
|
EBITDA
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
EBIT
1 |
2,738
|
1,788
|
1,365
|
1,292
|
2,682
|
1,384
|
-437
|
1,510
|
1,701
|
1,383
|
Operating Margin
|
13.79%
|
8.3%
|
11.49%
|
11.79%
|
11.61%
|
11.33%
|
-3.7%
|
5.88%
|
12.66%
|
10.28%
|
Earnings before Tax (EBT)
1 |
2,128
|
1,786
|
1,405
|
1,246
|
2,655
|
1,450
|
-405
|
1,540
|
1,772
|
1,160
|
Net income
1 |
1,800
|
1,244
|
994
|
882
|
1,845
|
1,011
|
-288
|
1,086
|
1,282
|
878
|
Net margin
|
9.06%
|
5.77%
|
8.37%
|
8.05%
|
7.99%
|
8.28%
|
-2.44%
|
4.23%
|
9.54%
|
6.53%
|
EPS
2 |
64.14
|
44.30
|
35.38
|
31.40
|
65.69
|
35.97
|
-10.28
|
38.68
|
45.59
|
31.27
|
Dividend per Share
|
24.00
|
24.00
|
-
|
-
|
24.00
|
-
|
-
|
50.00
|
-
|
-
|
Announcement Date
|
7/31/20
|
7/30/21
|
10/29/21
|
4/28/22
|
7/29/22
|
10/31/22
|
4/28/23
|
7/31/23
|
10/31/23
|
4/26/24
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Net Cash position
|
38,544
|
41,951
|
41,724
|
47,168
|
43,759
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
1 |
40,400
|
4,182
|
-1,654
|
1,912
|
-6,902
|
5,913
|
5,485
|
3,770
|
ROE (net income / shareholders' equity)
|
27.3%
|
3.1%
|
2.9%
|
3.3%
|
3.4%
|
3.9%
|
4.6%
|
5.35%
|
ROA (Net income/ Total Assets)
|
1.39%
|
3.74%
|
3.77%
|
4.19%
|
3.97%
|
3.5%
|
4.15%
|
4.75%
|
Assets
1 |
1,970,309
|
93,498
|
89,392
|
94,201
|
103,662
|
139,571
|
136,205
|
141,684
|
Book Value Per Share
2 |
4,029
|
4,098
|
4,165
|
4,243
|
4,274
|
4,312
|
4,402
|
4,520
|
Cash Flow per Share
2 |
1,010
|
145.0
|
135.0
|
157.0
|
163.0
|
182.0
|
188.0
|
208.0
|
Capex
1 |
419
|
217
|
150
|
508
|
168
|
1,030
|
1,450
|
1,600
|
Capex / Sales
|
0.97%
|
0.52%
|
0.32%
|
1.04%
|
0.31%
|
1.78%
|
2.37%
|
2.39%
|
Announcement Date
|
2/6/20
|
2/4/21
|
2/10/22
|
2/10/23
|
2/9/24
|
-
|
-
|
-
|
|
1st Jan change
|
Capi.
|
---|
| +11.39% | 708M | | +29.68% | 699B | | +25.07% | 571B | | -4.35% | 364B | | +17.65% | 326B | | +3.77% | 286B | | +14.68% | 236B | | +4.71% | 198B | | -12.43% | 194B | | -3.79% | 154B |
Other Pharmaceuticals
|